Northern Trust Corp Alkermes Plc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Alkermes Plc. stock. As of the latest transaction made, Northern Trust Corp holds 1,744,680 shares of ALKS stock, worth $49.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,744,680

Previous 1,772,751 1.58%

Holding current value

$49.5 Million

Previous $42.7 Million 14.3%

% of portfolio

0.01%

Previous 0.01%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$23.01 - $28.55 $645,913 - $801,427	-28,071 Reduced 1.58%	1,744,680 $48.8 Million
Q2 2024 Aug 14, 2024	SELL	$23.21 - $27.24 $560,916 - $658,309	-24,167 Reduced 1.34%	1,772,751 $42.7 Million
Q1 2024 May 14, 2024	SELL	$26.4 - $32.56 $1.24 Million - $1.53 Million	-46,913 Reduced 2.54%	1,796,918 $48.6 Million
Q4 2023 Feb 13, 2024	BUY	$23.37 - $28.68 $3.62 Million - $4.44 Million	154,944 Added 9.17%	1,843,831 $51.1 Million
Q3 2023 Nov 13, 2023	BUY	$27.17 - $31.97 $368,017 - $433,033	13,545 Added 0.81%	1,688,887 $47.3 Million
Q2 2023 Aug 11, 2023	BUY	$28.34 - $33.63 $1.18 Million - $1.4 Million	41,512 Added 2.54%	1,675,342 $52.4 Million
Q1 2023 May 15, 2023	BUY	$25.31 - $29.02 $478,637 - $548,797	18,911 Added 1.17%	1,633,830 $46.1 Million
Q4 2022 Feb 13, 2023	BUY	$21.94 - $26.24 $293,315 - $350,802	13,369 Added 0.83%	1,614,919 $42.2 Million
Q3 2022 Nov 14, 2022	SELL	$22.0 - $31.87 $293,238 - $424,795	-13,329 Reduced 0.83%	1,601,550 $35.8 Million
Q2 2022 Aug 12, 2022	SELL	$26.4 - $30.54 $467,359 - $540,649	-17,703 Reduced 1.08%	1,614,879 $48.1 Million
Q1 2022 May 13, 2022	SELL	$23.07 - $27.99 $1.89 Million - $2.29 Million	-81,979 Reduced 4.78%	1,632,582 $43 Million
Q4 2021 Feb 08, 2022	SELL	$21.47 - $32.08 $652,022 - $974,237	-30,369 Reduced 1.74%	1,714,561 $39.9 Million
Q3 2021 Nov 15, 2021	SELL	$23.37 - $32.13 $897,852 - $1.23 Million	-38,419 Reduced 2.15%	1,744,930 $53.8 Million
Q2 2021 Aug 13, 2021	BUY	$18.78 - $25.15 $19.3 Million - $25.8 Million	1,026,700 Added 135.69%	1,783,349 $43.7 Million
Q1 2021 May 12, 2021	BUY	$18.21 - $23.2 $326,396 - $415,836	17,924 Added 2.43%	756,649 $14.1 Million
Q4 2020 Feb 11, 2021	SELL	$15.39 - $22.1 $181,109 - $260,072	-11,768 Reduced 1.57%	738,725 $14.7 Million
Q3 2020 Nov 16, 2020	SELL	$16.16 - $20.66 $516,295 - $660,066	-31,949 Reduced 4.08%	750,493 $12.4 Million
Q2 2020 Aug 14, 2020	SELL	$13.31 - $19.41 $250,307 - $365,024	-18,806 Reduced 2.35%	782,442 $15.2 Million
Q1 2020 May 14, 2020	BUY	$13.06 - $21.24 $841,272 - $1.37 Million	64,416 Added 8.74%	801,248 $11.6 Million
Q4 2019 Feb 14, 2020	SELL	$17.29 - $21.74 $3.27 Million - $4.11 Million	-189,210 Reduced 20.43%	736,832 $15 Million
Q3 2019 Nov 13, 2019	SELL	$19.51 - $24.28 $128,785 - $160,272	-6,601 Reduced 0.71%	926,042 $18.1 Million
Q2 2019 Aug 13, 2019	BUY	$21.47 - $37.33 $310,262 - $539,455	14,451 Added 1.57%	932,643 $21 Million
Q1 2019 May 13, 2019	BUY	$28.4 - $36.49 $121,438 - $156,031	4,276 Added 0.47%	918,192 $33.5 Million
Q4 2018 Feb 12, 2019	BUY	$27.94 - $44.61 $1.63 Million - $2.61 Million	58,444 Added 6.83%	913,916 $27 Million
Q3 2018 Nov 14, 2018	SELL	$38.6 - $46.12 $792,380 - $946,751	-20,528 Reduced 2.34%	855,472 $36.3 Million
Q2 2018 Sep 18, 2018	SELL	$40.56 - $51.36 $431,639 - $546,573	-10,642 Reduced 1.2%	876,000 $36.1 Million
Q2 2018 Aug 14, 2018	BUY	$40.56 - $51.36 $1.47 Million - $1.86 Million	36,168 Added 4.25%	886,642 $36.5 Million
Q1 2018 May 09, 2018	SELL	$53.61 - $67.26 $443,837 - $556,845	-8,279 Reduced 0.96%	850,474 $49.3 Million
Q4 2017 Feb 14, 2018	BUY	$47.69 - $55.39 $21,460 - $24,925	450 Added 0.05%	858,753 $47 Million
Q3 2017 Nov 13, 2017	BUY	$49.16 - $54.45 $42.2 Million - $46.7 Million	858,303	858,303 $43.6 Million

Others Institutions Holding ALKS

# of Institutions

358

Shares Held

181M

Call Options Held

168K

Put Options Held

96.6K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.66B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Alkermes Plc. Transaction History